Share statistics (as at 2 January 2018)
|Number of Ordinary Shares in issue (undiluted)||120,696,002|
|Number of Ordinary Shares subject to options||6,507,500|
|Maximum number of Ordinary Shares in issue (fully diluted)||127,203,502|
The effect of the options, if all were exercised, would be to increase the issued share capital by 5.39% and raise £3,145,813 for the Company.
There are no restrictions on the transfer of Futura Medical plc shares.
Major shareholders (as at 2 January 2018)
Shareholders holding more than 3% of the share capital of Futura were:
|Lombard Odier Asset Management (Europe) Limited||18.9%|
|Octopus Asset Management||7.9%|
|WT Lamb Investments Limited||3.9%|
|Medinvest Holdings Limited||3.5%|
Shares not in public hands (as at 2 January 2018)
In terms of the AIM Rules and insofar as it is aware, 20.63% of the Company's AIM securities are not in public hands.
Shares held in treasury (as at 2 January 2018)
In terms of the AIM Rules, there are no shares held in treasury.
Share volumes (as at 2 January 2018)
The daily average number of shares traded since 2012 is:
|Daily Average Per Year Since 2012 ('000)||Daily Average Per Month in 2017 ('000)|
Share options (as at 2 January 2018)
The number of ordinary shares subject to options granted under the Share Option Schemes of the Company were:
|Grant||Exercise period (incl)||Exercise price/share||No of share options granted||Cash to Company on exercise|
|9/11||10/13 - 9/18||56.50p||627,500||£354,538|
|9/12||10/14 - 9/19||61.50p||660,000||£405,900|
|9/13||10/15 - 9/20||71.50p||750,000||£536,250|
|9/14||10/16 - 9/21||51.75p||710,000||£367,425|
|9/15||10/17 - 9/22||30.00p||1,060,000||£318,000|
|1/17||10/18 - 9/23||57.50p||1,260,000||£724,500|
|9/17||10/19 - 9/24||30.50p||1,440,000||£439,200|
Further details of share options issued can be obtained from the Company's Annual Report 2016 which can be found in the Annual and Interim Reports section.
Page last updated: 9 January 2018